Prosecution Insights
Last updated: May 29, 2026

Examiner: MOREAU, NASHARA LOUISE

Tech Center 1700 • Art Units: 1611 1628 1655 1792

This examiner grants 100% of resolved cases

Performance Statistics

100.0%
Allow Rate
+35.0% vs TC avg
33
Total Applications
+0.0%
Interview Lift
864
Avg Prosecution Days
Based on 3 resolved cases, 2023–2026

Rejection Statute Breakdown

2.5%
§101 Eligibility
10.0%
§102 Novelty
85.0%
§103 Obviousness
2.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17865953 COMPOSITIONS FOR CONTROLLING ARTHROPODS Non-Final OA The Procter & Gamble Company
18435415 COMPOSITION FOR PREVENTING OR TREATING MUSCULAR DISEASE CONTAINING PONCIRI FRUCTUS EXTRACT Non-Final OA KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
18540186 Composition for the prevention, improvement or treatment of allergic diseases comprising an extract of Cassia mimosoides L. as an active ingredient Non-Final OA KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
18515599 COMPOSITION FOR ANTI-OBESITY COMPRISING GREEN TEA PEPTIDE COMPOSITION Non-Final OA AMOREPACIFIC CORPORATION
18012533 MYCELIAL CULTURE OF Irpex lacteus AND COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTION AND TREATMENT OF DIABETES MEILLITUS Non-Final OA Jianmin LI
18607436 COMPOSITIONS WITH IMPROVED SOLUBILITY OF POOR-WATER-SOLUBLE AGENTS AND METHODS OF MAKING Non-Final OA Giffin Technologies Inc.
18692547 COSMETIC COMPOSITION FOR USE ON THE SKIN Non-Final OA Roval Fern GmbH
18684682 COMPOSITION COMPRISING PASTEURIZED AKKERMANSIA FOR THE TREATMENT OR PREVENTION OF IBS-RELATED ANXIETY Non-Final OA THE AKKERMANSIA COMPANY
18518451 METHOD FOR REGULATING IMMUNITY BY USING BLACK HULLESS BARLEY EXTRACT Final Rejection TCI CO., LTD.
18294264 ACTIVE INGREDIENT COMPRISING OLIGO-GLUCANS DERIVED FROM THE CYTOSOLIC FRACTION OF SACCHAROMYCES CEREVISIAE, AND COSMETIC USES THEREOF Non-Final OA SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE
18417113 METHOD FOR IMPROVING COGNITIVE FUNCTION AND A DIETARY SUPPLEMENT FOR USE IN THE METHOD Non-Final OA RB Health (US) LLC
18574806 GYNECOMASTIA AND/OR MASTALGIA TREATMENT Non-Final OA BioZen Limited
18575018 USE OF CISTANCHE TUBULOSA EXTRACT IN THE PREPARATION OF A MEDICAMENT FOR RELIEVING DRY EYE SYNDROME Non-Final OA SINPHAR TIAN-LI PHARMACEUTICAL CO., LTD. (HANGZHOU)
18519093 ONION EXTRACT, THE PREPARATION THEREOF AND THE USE FOR PROMOTING HAIR GROWTH THEREOF Non-Final OA FORMOSA BIOMEDICAL TECHNOLOGY CORPORATION
18563001 BACTERIAL CELL WALL BOUND TO A MUCOPOLYSACCHARIDE, USES THEREOF AND PROCESS FOR ITS PRODUCTION Non-Final OA AILEENS PHARMA S.R.L.
18506200 SKIN MOISTURIZING FUNCTIONAL TRANSFERSOME COSMETIC COMPOSITION AND METHOD OF PREPARING THE SAME Non-Final OA RADKIN
18005721 ANTI-HYPERCHOLESTEROLEMIA COMPOSITION AND A METHOD OF MANUFACTURING THE SAME Non-Final OA NBI BIOSCIENCES PRIVATE LIMITED

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month